- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
VBI Vaccines (NASDAQ:VBIV), Quotes and News Summary
VBI Vaccines (NASDAQ: VBIV)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-01 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.080 | -0.080 | 0.0000 | ||||
| REV | 90.000K | 126.000K | 36.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
VBI Vaccines Questions & Answers
You can purchase shares of VBI Vaccines (NASDAQ: VBIV) through any online brokerage.
There are no as such competitors for VBI Vaccines.
The latest price target for VBI Vaccines (NASDAQ: VBIV) was reported by Raymond James on Tuesday, March 8, 2022. The analyst firm set a price target for 6.00 expecting VBIV to rise to within 12 months (a possible 611.32% upside). 1 analyst firms have reported ratings in the last year.
The stock price for VBI Vaccines (NASDAQ: VBIV) is $0.8435 last updated May 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for VBI Vaccines.
VBI Vaccines’s Q2 earnings are confirmed for Monday, August 1, 2022.
There is no upcoming split for VBI Vaccines.
VBI Vaccines is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.